Cabot Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-45,547
Closed -$12M 142
2022
Q4
$12M Sell
45,547
-10,896
-19% -$2.92M 2.02% 15
2022
Q3
$12.7M Sell
56,443
-158
-0.3% -$38.3K 2.15% 10
2022
Q2
$13.8M Sell
56,601
-280
-0.5% -$68.6K 2.18% 10
2022
Q1
$13.8M Buy
56,881
+549
+1% +$126K 1.85% 18
2021
Q4
$12.7M Buy
56,332
+4,467
+9% +$943K 1.61% 24
2021
Q3
$11M Buy
51,865
+2,174
+4% +$500K 1.48% 27
2021
Q2
$12.1M Buy
49,691
+602
+1% +$148K 1.62% 24
2021
Q1
$12.2M Sell
49,089
-2,685
-5% -$641K 1.72% 23
2020
Q4
$11.9M Buy
51,774
+3,797
+8% +$875K 1.83% 17
2020
Q3
$12.2M Buy
47,977
+538
+1% +$133K 2.22% 10
2020
Q2
$11.2M Buy
47,439
+227
+0.5% +$51.8K 2.23% 10
2020
Q1
$9.57M Sell
47,212
-35
-0.1% -$7.64K 2.29% 9
2019
Q4
$11.4M Buy
47,247
+10,868
+30% +$2.4M 2.2% 11
2019
Q3
$7.04M Buy
36,379
+790
+2% +$152K 1.49% 24
2019
Q2
$6.56M Buy
35,589
+542
+2% +$97K 1.38% 26
2019
Q1
$6.66M Buy
35,047
+18,694
+114% +$3.57M 1.46% 25
2018
Q4
$3.18M Buy
+16,353
New +$3.19M 0.78% 47

Other funds holding AMGN

Cabot Wealth Management's AMGN Position: Q1 2023 in Review

Cabot Wealth Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 45,547 shares — an estimated $12M sold.

Cabot Wealth Management first reported a position in AMGN in Q4 2018 and held it in 17 quarters. The position peaked at $13.8M in Q2 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Cabot Wealth Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Cabot Wealth Management sold 45,547 Amgen shares in Q1 2023, an estimated $12M.
  • Cabot Wealth Management first reported a position in Amgen in Q4 2018 and held it in 17 quarters.
  • Cabot Wealth Management's Amgen position peaked at $13.8M in Q2 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Cabot Wealth Management's 13F filing for Q1 2023, filed 20 Apr 2023.